Global Health Ltd.

NSE: MEDANTA · Healthcare

₹1,387.60-0.15%06 Nov 2026

Ask the data

Instant answers about Global Health Ltd. — computed from its filings, no language model

Market cap₹37,281 cr

Current price₹1,387.60

High / Low₹1,509 / ₹961

P/E93.7

P/B8.62

Book value₹160.9

ROE9.2%

ROCE18.3%

Debt / equity0.16

Dividend yield0.04%

EPS (TTM)₹14.80

Face value₹2

Price & valuation

split & bonus adjusted · pick a metric and range

Annual performance

annual · ₹ crore · line = operating margin

	FY23	FY24	FY25	FY26
Revenue	2,694	3,275	3,692	4,410
EBITDA	612	799	877	919
Operating margin	22.7%	24.4%	23.8%	20.8%
Interest	78	74	65	79
Depreciation	150	173	194	223
Profit before tax	449	627	647	715
Tax	123	149	166	161
Net profit	326	478	481	556
EPS ₹	12.58	17.80	17.92	20.71
Operating cash flow	645	612	624	714
Capex	236	279	517	838
Dividend paid	0	0	0	13
Total assets	4,116	4,304	4,766	5,905
Equity	2,428	2,906	3,386	3,962

Quarterly performance

last 16 quarters · ₹ crore

showing latest 8 of 16 periods

	DEC '22	MAR '23	JUN '23	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
Revenue	694	703	773	844	833	809	861	957	943	931	1,031	1,099	1,121	1,159	1,304	1,469
Operating profit	160	163	178	213	212	179	186	228	238	225	227	231	217	244	287	370
Operating margin	23.0%	23.2%	23.0%	25.2%	25.5%	22.2%	21.6%	23.9%	25.2%	24.1%	22.0%	21.0%	19.4%	21.0%	22.0%	25.2%
Other income	12	28	21	21	22	27	22	18	16	23	20	20	22	37	22	24
Interest	21	20	18	20	18	18	18	16	16	15	14	17	22	27	27	28
Depreciation	39	38	40	43	44	45	47	49	48	49	45	50	61	67	69	71
Profit before tax	112	133	141	171	172	143	144	181	189	133	208	200	120	187	213	295
Tax	32	32	39	45	49	16	37	50	46	32	49	41	25	46	56	76
Net profit	81	101	0	125	124	127	106	131	143	101	159	158	95	144	159	0
EPS ₹	3.08	3.77	3.80	4.66	4.61	4.74	3.96	4.87	5.32	3.77	5.92	5.89	3.54	5.36	5.91	8.21
Revenue YoY	—	—	—	—	19.9%	15.0%	11.4%	13.3%	13.3%	15.2%	19.7%	14.9%	18.8%	24.5%	26.5%	33.6%
Profit YoY	—	—	—	—	53.4%	26.0%	—	4.5%	15.6%	-20.4%	49.6%	21.1%	-33.5%	42.0%	-0.2%	-100.0%

Returns & margins

trailing-twelve-month, per quarter

showing latest 8 of 13 periods

	SEP '23	DEC '23	MAR '24	JUN '24	SEP '24	DEC '24	MAR '25	JUN '25	SEP '25	DEC '25	MAR '26	JUN '26	SEP '26
ROE	11.6%	13.2%	12.9%	16.6%	15.5%	16.2%	14.2%	15.8%	15.2%	13.9%	14.0%	14.0%	9.2%
ROCE	20.6%	22.4%	21.1%	21.2%	20.6%	21.1%	19.2%	20.8%	18.7%	17.2%	15.4%	15.8%	18.3%
Net margin	10.2%	11.1%	11.5%	14.4%	14.1%	14.2%	13.0%	13.8%	14.0%	12.3%	12.6%	11.9%	7.9%
EBITDA margin	23.7%	24.3%	24.0%	23.6%	23.3%	23.3%	23.8%	23.8%	23.0%	21.5%	20.8%	20.9%	22.1%
Debt / equity	0.17	0.17	0.14	0.14	0.10	0.10	0.10	0.10	0.14	0.14	0.30	0.30	0.16
Interest coverage	8.04	9.10	9.48	9.51	10.16	10.60	10.92	12.66	12.74	10.80	10.04	8.83	8.91
Asset turnover	0.74	0.77	0.76	0.78	0.77	0.79	0.77	0.81	0.74	0.77	0.75	0.79	0.76

Balance sheet

equity vs borrowings over time · ₹ crore

showing latest 6 of 8 periods

	MAR '23	SEP '23	MAR '24	SEP '24	MAR '25	SEP '25	MAR '26	SEP '26
Share capital	54	54	54	54	54	54	54	54
Other equity / reserves	2,375	2,600	2,852	3,088	3,333	3,654	3,908	4,270
Total equity	2,428	2,654	2,906	3,141	3,386	3,708	3,962	4,323
Borrowings	842	441	419	302	328	527	1,190	695
Current liabilities	573	641	618	653	619	721	627	768
Non-current liabilities	1,115	784	781	715	760	979	1,294	1,495
Total assets	4,116	4,079	4,304	4,510	4,766	5,410	5,905	6,606
Property, plant & equipment	1,708	1,750	1,813	1,910	1,975	3,184	3,779	3,937
Capital work-in-progress	327	351	386	453	529	318	132	207
Investments	0	0	0	3	3	3	3	3
Inventories	60	73	67	76	67	73	79	88
Receivables	194	257	215	283	292	365	411	522
Cash & equivalents	767	354	425	300	230	759	127	296

Cash flow

annual · ₹ crore · line = free cash flow

	FY23	FY24	FY25	FY26
Cash from operations	645	612	624	714
Cash from investing	-342	-441	-721	-1,065
Cash from financing	346	-514	-97	248
Capex	236	279	517	838
Free cash flow	409	334	107	-124
Dividends paid	0	0	0	13

Where the assets sit

Sep '26 · ₹ crore

Fixed assets (PPE)

₹3,937 cr60%

CWIP

₹207 cr3%

Investments

₹3 cr0%

Inventories

₹88 cr1%

Receivables

₹522 cr8%

Cash & equivalents

₹296 cr4%

Other assets

₹1,553 cr24%

Peer comparison

largest in Healthcare · this company in bold

Company	Market cap ₹cr	Price	P/E	P/B	ROE
Sun Pharmaceutical Industries Ltd.	4,46,270	1,860.00	40.7	5.00	12.3%
Divi's Laboratories Ltd.	2,73,493	10,320.50	93.5	16.32	17.5%
Torrent Pharmaceuticals Ltd.	1,80,671	4,750.00	85.1	9.83	11.6%
Laurus Labs Ltd.	1,26,430	2,340.00	94.4	20.86	22.1%
Apollo Hospitals Enterprise Ltd.	1,21,453	8,446.00	54.2	11.45	21.1%
Zydus Lifesciences Ltd.	1,19,550	1,197.90	28.6	4.30	15.0%
Dr. Reddy's Laboratories Ltd.	1,14,646	1,373.00	40.9	2.95	7.2%
Cipla Ltd.	1,13,988	1,411.00	39.3	3.22	8.2%
Mankind Pharma Ltd.	1,04,902	2,540.00	46.7	5.97	12.8%
Aurobindo Pharma Ltd.	1,03,572	1,800.00	26.0	2.63	10.1%
Global Health Ltd.	37,281	1,387.60	93.7	8.62	9.2%

StoxGud checklist: Neutral setup · 6/10

Price above 50-day average
Price above 200-day average
50-day average above 200-day (uptrend)
RSI in healthy 40–70 zone
Positive 1-year return
Return on equity above 15%
Debt to equity below 1
Revenue growing year on year
Net profit margin above 10%
P/E below industry median

A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.

Returns & technicals

1 month+7.2%

6 months+15.0%

1 year+0.9%

3Y CAGR+18.3%

5Y CAGR—

10Y CAGR—

50-day avg₹1,372.87

200-day avg₹1,248.47

RSI (14)71

Compare Global Health Ltd. with

Ajanta Pharmaceuticals vs Global Health Narayana Hrudayalaya vs Global Health Sai Life Sciences vs Global Health Global Health vs Aster DM Quality Care

FAQs

What is the share price of Global Health Ltd.?

Global Health Ltd. (MEDANTA) closed at ₹1,387.60 on NSE on 06 Nov 2026.

What is the market cap of Global Health Ltd.?

₹37,281 crore at the latest close.

What is the P/E ratio of Global Health Ltd.?

93.7, on trailing-twelve-month earnings from its filings.

How fast is Global Health Ltd. growing?

Global Health Ltd.: revenue has compounded at 17.9% a year over three years; net profit at 19.5% a year. Latest-quarter revenue is up 33.6% year on year, profit down 100.0%.

How profitable is Global Health Ltd.?

On a trailing-twelve-month basis return on equity is 9.2%, return on capital employed 18.3%, operating margin 22.1%, net margin 7.9%.

How much debt does Global Health Ltd. have?

Global Health Ltd. is lightly geared: debt to equity is 0.16 with borrowings of ₹695 cr against cash of ₹296 cr (balance sheet of 2026-09-30). Operating profit covers interest 8.9 times.

Financials parsed from Global Health Ltd.'s own XBRL filings to NSE (consolidated), ₹ crore unless marked. Quarterly from DEC '22, annual from FY23, balance sheet from Mar '23. * = derived (full year or half year minus earlier quarters). Information only, not investment advice.